Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

wall motion in these viable segments may further improve or diminish, reflecting inducible
ischemia. This “biphasic response” is highly predictive of recovery of function after …

ABSTRACT Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Objectives: We conducted a randomized trial to assess the effectiveness of F-18-
fluorodeoxyglucose (FDG) positron emission tomography (PET)-assisted management in …

Approximately 50% of the patients with chronic obstructive coronary artery disease resulting
in chronic contractile dysfunction have hibernating myocardium and may benefit from …

Objectives: We sought to determine: 1) whether F-18-fluorodeoxyglucose (FDG) positron
emission tomography (PET) parameters identify high-risk patients who gain benefit from …

In developed countries, coronary artery disease (CAD) continues to be a major cause of
death and disability. Over the past two decades, positron emission tomography (PET) …

The purpose of this study was to compare the prognostic value of left ventricular ejection
fraction (LVEF) and myocardial perfusion reserve (MPR) assessed with PET in patients with …

18F-FDG PET may assist decision making in ischemic cardiomyopathy. The PET and
Recovery Following Revascularization (PARR 2) trial demonstrated a trend toward …

Objectives: Evaluate whether PCI in combination with optimal medical therapy (OMT) will
reduce all-cause death and hospitalization for HF compared to a strategy of OMT alone …